• Home
  • Stock
  • Aarti Drugs Fundamental Analysis
  • Aarti Drugs Fundamental Analysis

Aarti Drugs fundamental analysis

AARTIDRUGS

HealthcareMid

404.1

3.75 (-0.92%)
Last updated on 6 Dec, 2025 | 14:05 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Aarti Drugs Fundamentals

P/E Ratio

18.56

P/B Ratio

2.52

Div. Yield

0.25

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

  • Aarti Drugs Fundamentals is currently trading with a P/E Ratio of 18.56, compared to the sector average of 36.18. Its P/B Ratio stands at 2.52, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 0.25%, which is than the sector’s 0.56%.

Aarti Drugs Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Aarti Drugs reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.